Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Anaptysbio (ANAB) over the last 11 years, with Q3 2025 value amounting to $38.1 million.

  • Anaptysbio's Total Current Liabilities fell 1316.32% to $38.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.1 million, marking a year-over-year decrease of 1316.32%. This contributed to the annual value of $45.4 million for FY2024, which is 2132.9% up from last year.
  • Anaptysbio's Total Current Liabilities amounted to $38.1 million in Q3 2025, which was down 1316.32% from $35.5 million recorded in Q2 2025.
  • Anaptysbio's Total Current Liabilities' 5-year high stood at $45.4 million during Q4 2024, with a 5-year trough of $14.5 million in Q1 2021.
  • Moreover, its 5-year median value for Total Current Liabilities was $35.5 million (2025), whereas its average is $31.2 million.
  • Per our database at Business Quant, Anaptysbio's Total Current Liabilities tumbled by 3774.19% in 2021 and then soared by 10950.63% in 2023.
  • Over the past 5 years, Anaptysbio's Total Current Liabilities (Quarter) stood at $16.1 million in 2021, then surged by 61.84% to $26.1 million in 2022, then surged by 43.71% to $37.4 million in 2023, then rose by 21.33% to $45.4 million in 2024, then dropped by 16.12% to $38.1 million in 2025.
  • Its last three reported values are $38.1 million in Q3 2025, $35.5 million for Q2 2025, and $44.0 million during Q1 2025.